TE_38954
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2a_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | ENSG00000291034, ARSFP1 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.45 |
| Counts of samples | TCGA_tumor:74; TCGA_normal:19; GTEx:168 |
| TSS | chrY(-):12289943 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38954.1 | ENSG00000291034, ARSFP1 | Chimeric | Non-coding | Non-coding | chrY(-):12206563,12206583,12241371,12241408,12253986,12254107,12289803,12289944 |
| teRNA_38954.2 | ENSG00000291034, ARSFP1 | Chimeric | Non-coding | Non-coding | chrY(-):12252498,12252518,12253981,12254107,12289803,12289944 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
